The Center for Structural Genomics of Infectious Diseases is a consortium of laboratories using state-of-the-art structural biology methods to determine the 3-D structures of proteins from major human pathogens (see Overview for more detailed information about our mission).
February 2010: Protein determined by CSGID featured as the NIAID structure of the month.
November 2009: Protein determined by CSGID featured as the NIAID structure of the month.
August 13th, 2009: The CSGID has determined its 100th protein structure. For more information, read our press releases: (Northwestern University) (University of Virginia)
The laboratories participating in the CSGID are:
UT Southwestern Medical Center at Dallas
Washington University School of Medicine
Targets requested by the community: 815
Targets with structures: 129
Structures: 149
Structures complexed with ligands: 35
Structures requested by the community: 12
Publications: 6
Title: Crystal structure of pre-cleavage form of cysteine protease domain from Vibrio cholerae RtxA toxin
Authors:
Title: Crystal Structure of Type I 3-Dehydroquinate Dehydratase (aroD) from Clostridium difficile with Covalent Reaction Intermediate. Authors:
Title: Structure of the type III effector/phosphothreonine lyase OspF from Shigella flexneriAuthors:
Title: 1.77 Angstrom resolution crystal structure of orotidine 5'-phosphate decarboxylase from Vibrio cholerae O1 biovar eltor str. N16961Authors:
Title: Phosphopantetheine adenylyltransferase from Yersinia pestis complexed with coenzyme A.Authors:
Title: Crystal structure of transketolase from Campylobacter jejuni subsp. jejuni NCTC 11168Authors:
Title: Crystal Structure of Dihydrodipicolinate Synthase Campylobacter jejuni subsp. jejuni NCTC 11168Authors:
Title: 1.85 Angstrom Crystal Structure of the 3-Dehydroquinate Dehydratase (aroD) from Salmonella typhimurium LT2.Authors:
Title: Crystal Structure of the 3-Dehydroquinate Dehydratase (aroD) from Salmonella typhimurium LT2 with Citrate Bound to the Active Site.Authors:
This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200700058C.
